Will Teladoc Health (TDOC) beat quarterly earnings?
🗂 Part of event: Will Teladoc Health (TDOC) beat quarterly earnings? →💡 What the odds say
The market puts this at about a 43% chance — less likely than not.
No money — just record your call and see if you were right. Yes is at 43% right now.
Data from Polymarket’s public API, for informational purposes only. PredictPal is not affiliated with any platform and does not facilitate trading.
Discussion
Loading…
How it resolves
Settled on-chain by UMA's optimistic oracle: once an outcome is clear, anyone can propose the result, which then enters a challenge window where it can be disputed with evidence before it finalizes.
⚖️ A proposed outcome can be disputed during a challenge window before it's final.
Resolution criteria
As of market creation, Teladoc Health is estimated to release earnings on July 29, 2026. The Street consensus estimate for Teladoc Health's GAAP EPS for the relevant quarter is $-0.25 as of market creation. This market will resolve to "Yes" if Teladoc Health reports GAAP EPS greater than $-0.25 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Teladoc Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Related markets
Next target for the US interest rate (July)
4 outcomes
Number of FOMC meetings with FED interest rate cuts in the US in 2026
7 outcomes